|
The Motley Fool Discussion Boards
|
Previous Page | |
|
Industry Discussions / Pharmaceuticals |
||
|
URL:
http://boards.fool.com/trius-pharmaceuticals-30211768.aspx
|
||
| Subject: Trius Pharmaceuticals | Date: 8/18/2012 10:13 AM | |
| Author: pedropan1 | Number: 889 of 892 | |
|
Request opinion of other members on Trius. Main target short term for this company is Staph aureus market, specifically MRSA. Only competing drug is linezolid, a Pfizer product. Linezolid market roughly 1.5 billion yearly. Trius tint but seems on track. Interested on hearing from others on possible negatives (or positives) |
||
| Copyright 1996-2013 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us | ||